Human CD74/CLIP/DHLAG ORF/cDNA clone-Mammalian (Non-Viral Vector) plasmid (NM_004355.4)
Cat. No.: pGMPC001530
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human CD74/CLIP/DHLAG Non-Viral expression plasmid (overexpression vector) for mouse CD74 overexpression in unique cell transient transfection and stable cell line development.
Go to
CD74/CLIP products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMPC001530 |
| Gene Name | CD74 |
| Accession Number | NM_004355.4 |
| Gene ID | 972 |
| Species | Human |
| Product Type | Mammalian (Non-Viral Vector) plasmid (overexpression) |
| Insert Length | 699 bp |
| Gene Alias | CLIP,DHLAG,HLADG,Ia-GAMMA,II,p33 |
| Fluorescent Reporter | EGFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGCACAGGAGGAGAAGCAGGAGCTGTCGGGAAGATCAGAAGCCAGTCATGGATGACCAGCGCGACCTTATCTCCAACAATGAGCAACTGCCCATGCTGGGCCGGCGCCCTGGGGCCCCGGAGAGCAAGTGCAGCCGCGGAGCCCTGTACACAGGCTTTTCCATCCTGGTGACTCTGCTCCTCGCTGGCCAGGCCACCACCGCCTACTTCCTGTACCAGCAGCAGGGCCGGCTGGACAAACTGACAGTCACCTCCCAGAACCTGCAGCTGGAGAACCTGCGCATGAAGCTTCCCAAGCCTCCCAAGCCTGTGAGCAAGATGCGCATGGCCACCCCGCTGCTGATGCAGGCGCTGCCCATGGGAGCCCTGCCCCAGGGGCCCATGCAGAATGCCACCAAGTATGGCAACATGACAGAGGACCATGTGATGCACCTGCTCCAGAATGCTGACCCCCTGAAGGTGTACCCGCCACTGAAGGGGAGCTTCCCGGAGAACCTGAGACACCTTAAGAACACCATGGAGACCATAGACTGGAAGGTCTTTGAGAGCTGGATGCACCATTGGCTCCTGTTTGAAATGAGCAGGCACTCCTTGGAGCAAAAGCCCACTGACGCTCCACCGAAAGAGTCACTGGAACTGGAGGACCCGTCTTCTGGGCTGGGTGTGACCAAGCAGGATCTGGGCCCAGTCCCCATGTGA |
| ORF Protein Sequence | MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKVFESWMHHWLLFEMSRHSLEQKPTDAPPKESLELEDPSSGLGVTKQDLGPVPM |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Biosimilar | GMP-Bios-ab-344 | Pre-Made Milatuzumab biosimilar, Whole mAb, Anti-CD74 Antibody: Anti-CLIP/DHLAG/HLADG/II/Ia-GAMMA/p33 therapeutic antibody |
| Target Antibody | GM-Tg-g-T08231-Ab | Anti-HG2A/ CD74/ DHLAG monoclonal antibody |
| Target Antigen | GM-Tg-g-T08231-Ag | CD74 VLP (virus-like particle) |
| ORF Viral Vector | pGMLP004927 | Human CD74 Lentivirus plasmid |
| ORF Viral Vector | pGMAP000261 | Human CD74 Adenovirus plasmid |
| ORF Viral Vector | pGMPC001530 | Human CD74 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLP004927 | Human CD74 Lentivirus particle |
| ORF Viral Vector | vGMAP000261 | Human CD74 Adenovirus particle |
Target information
| Target ID | GM-T08231 |
| Target Name | CD74 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
972 |
| Gene ID |
100071644 (Equus caballus), 101085953 (Felis catus), 16149 (Mus musculus), 25599 (Rattus norvegicus) 479329 (Canis lupus familiaris), 613384 (Bos taurus), 710820 (Macaca mulatta), 972 (Homo sapiens) |
| Gene Symbols & Synonyms | CD74,Cd74,Ii,CLIP,DHLAG,HLADG,Ia-GAMMA,INVG34,II,p33 |
| Target Alternative Names | CD74,CLIP,Cd74,DHLAG,HLA class II histocompatibility antigen gamma chain,HLA-DR antigens-associated invariant chain,HLADG,II,INVG34,Ia antigen-associated invariant chain (Ii),Ia-GAMMA,Ii,p33 |
| Uniprot Accession |
P04233,P04441,P10247
Additional SwissProt Accessions: P04441,P10247,P04233 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target, INN Index |
| Disease | cancer |
| Disease from KEGG | Antigen processing and presentation, Tuberculosis |
| Gene Ensembl | ENSECAG00000008503, ENSMUSG00000024610, ENSCAFG00845006874, ENSBTAG00000015228, ENSMMUG00000009113, ENSG00000019582 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


